Evaluation of a New Prognostic Risk Assessment Tool (CHIP Score) for Interventional Treatment in NSTE-ACS Patients: A Retrospective Cohort Analysis from a Single Center Involving 348 Individuals - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluation of a New Prognostic Risk Assessment Tool (CHIP Score) for Interventional Treatment in NSTE-ACS Patients: A Retrospective Cohort Analysis from a Single Center Involving 348 Individuals

  • By

  • Qichang Zhu

  • Yuan Zhang

  • Jiaxin Liu

  • Xin Wang

  • Jiayu Meng

  • Hongwei Tian

  • January 8, 2026

Share

  • 1

    The CHIP Score was developed to assess risk in complex high-risk coronary heart disease patients undergoing interventional treatment.

  • 2

    This study analyzed 348 NSTE-ACS patients to evaluate the predictive efficacy of the CHIP Score for major adverse cardiovascular events.

  • 3

    Patients were categorized into four groups based on their CHIP Score, with follow-up conducted over 36 months to track adverse events.

  • 4

    The primary outcome measured was major adverse cardiovascular and cerebrovascular events, including cardiovascular death and unplanned revascularization.

  • 5

    Statistical analyses included Kaplan-Meier survival curves and Cox proportional hazards model to identify independent risk factors for CHIP patients.

Original Source(s)

Evaluation of a New Prognostic Risk Assessment Tool (CHIP Score) for Interventional Treatment in NSTE-ACS Patients: A Retrospective Cohort Analysis from a Single Center Involving 348 Individuals

  • by Qichang Zhu, Yuan Zhang, Jiaxin Liu, Xin Wang, Jiayu Meng, Hongwei Tian

  • January 8, 2026

Related Content

Shifts in Lipid-Lowering Treatment Approaches for Acute Coronary Syndromes Following New Insurance Policies in China: An Analysis Based on Real-World Data

Relationship of Initial Blood Glucose Levels to Atypical Angina in Individuals with Coronary Artery Disease

Outcomes of Percutaneous Coronary Intervention in Hospitalized Patients with Acute Coronary Syndrome and Heart Failure: Insights from the CCC-ACS Registry Observational Study